US Pharma MarketingThe post Patient enrolment concludes in Glaukos’ Preserflo MicroShunt trial appeared first on Medical Device Network.
Patient enrolment concludes in Glaukos’ Preserflo MicroShunt trial
Glaukos has concluded patient enrolment in its US 510(k) pivotal trial assessing the Preserflo MicroShunt drainage device in adults with primary open-angle glaucoma. The post Patient enrolment concludes in Glaukos’ Preserflo MicroShunt trial appeared first on Medical Device Network .
Glaukos has concluded patient enrolment in its US 510(k) pivotal trial assessing the Preserflo MicroShunt drainage device in adults with primary open-angle glaucoma.
Source: Medical Device Network